Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Gregory Lucier

OTHER INVESTOR TYPE
4 INVESTMENTS
1 PORTFOLIO
2 EXITS
Description

Mr. Gregory Lucier serves as Chief Executive Officer at Corza Health. He serves as Chairman of the Board at NuVasive. Previously, He served as Chief Executive Officer at NuVasive. Lucier also serves as Chairman and previously as Chief Financial Officer at Invuity. He is also serves as Board Member at Cole-Parmer. An established strategic thought leader and business executive in the Life Sciences, Medical Device and Healthcare Technology sectors, Mr. Lucier is a proven game-changer with an eye for innovative technologies that will radically alter healthcare in the 21st century. Known for his success in the capacity of Chief Executive Officer and in Board Director roles, he has demonstrated expertise in guiding enterprise growth through his focus on the integration of internal operating assets, building innovation capabilities, making accretive acquisitions, creating IP portfolios, expanding globally, and repositioning business models. As Chairman and CEO of NuVasive, a medical device company that has transformed spine surgery by pioneering minimally invasive lateral approach spine surgery, Mr. Lucier and his team pushed the boundaries of medical device innovation with their game-changing Integrated Global Alignment™ procedural solution, which is poised to change, yet again, how spine surgery is done. Mr. Lucier's vision on the power of genomics to eradicate disease states, such as cancer, led the growth trajectory of Life Technologies Corporation during the eleven years he served as Chairman and CEO. The company was at the forefront genomics research, providing more than 50,000 laboratory and genomic testing products to customers in 180 countries, holding over 5,000 essential patents, with $4 billion in revenue to the acquisition by Thermo Fisher Scientific in 2013 for $15.6 billion - one of the largest Life Sciences acquisitions to date. Mr. Lucier's career with General Electric was focused on starting up and transforming major business models. During his tenure he served as President, Medical Information Technologies/GE Healthcare, overseeing the networking of medical electronic devices, digital imaging and clinical information systems with revenues of $1.8 billion. He was promoted by the GE Board to an officer of General Electric Corporation to serve as Vice President Global Services, GE Healthcare, the company's $2 billion healthcare services business where he successfully led the transformation from a machine maintenance focus to GE being regarded as a powerhouse remote diagnostics. Mr. Lucier received a BS (Bachelor of Science in engineering from Pennsylvania State University and a masters of business administration from Harvard Business School. In addition to serving on the Board of NuVasive, he is a member of the Board of Directors for Catalent, Inc. and Invuity, Inc. Additionally, Mr. Lucier is a former Chairman of the Board of Life Technologies and director of CareFusion Corporation, now part of Becton, Dickinson & Co. He also serves as Limited Partner at Lakeshore Capital Partners.

Primary Investor Type
Angel (individual)
Primary Office
  • San Francisco, CA
  • United States

Gregory Lucier Investments (4)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Corza Health 20-Mar-2019 Platform Creation Other Healthcare Technology Systems Startup 0000000 000000
00000 000000 09-May-2017 00000 00000 0000 Diagnostic Equipment Generating Revenue 0000000 000000
Invuity 09-Mar-2015 Later Stage VC 000.00 Surgical Devices Generating Revenue/Not Profitable 0000000 000000
Edico Genome 28-Mar-2014 Early Stage VC 00.000 Diagnostic Equipment Generating Revenue 0000000 000000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Gregory Lucier’s full profile, request a free trial.

Gregory Lucier Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
Edico Genome 14-May-2018 Merger/Acquisition 00000 Completed
0000000 15-Jun-2015 000 0000 Completed
To view this investor’s complete exits history, request access »

Gregory Lucier Team (1)

Name Title Deals Funds Boards Office Contact
Info
Gregory Lucier Angel Investor 00 0 San Francisco, CA